Results 161 to 170 of about 181,344 (173)

EML4-ALK enhances programmed cell death-ligand 1 expression in pulmonary adenocarcinoma via hypoxia-inducible factor (HIF)-1α and STAT3

OncoImmunology, 2016
Jaemoon Koh, Bhumsuk Keam, Sehui Kim
exaly  

The influence of programmed cell death ligand 2 (PD-L2) expression on survival outcome and tumor microenvironment in diffuse large B cell lymphoma

Leukemia and Lymphoma, 2020
Kitsada Wudhikarn, Thamathorn Assanasen, Narittee Sukswai   +2 more
exaly  

Programmed cell death ligand 1 and tumor‐infiltrating lymphocyte status in patients with renal cell carcinoma and sarcomatoid dedifferentiation

Cancer, 2017
Fumi Kawakami, Jaime Rodriguez-Canales, Bryan Fellman   +2 more
exaly  

Programmed death ligand 1 testing in non–small cell lung carcinoma cytology cell block and aspirate smear preparations

Cancer Cytopathology, 2018
Wei-Lien Wang, Yun Gong, Jun Zhao
exaly  

A Randomized Non-Comparative Phase II Study of Anti-Programmed Cell Death-Ligand 1 Atezolizumab or Chemotherapy as Second-Line Therapy in Patients With Small Cell Lung Cancer: Results From the IFCT-1603 Trial

Journal of Thoracic Oncology, 2019
Jean-Louis Pujol, Laurent Greillier, Florian Guisier   +2 more
exaly  

Impact of Patient Characteristics, Prior Therapy, and Sample Type on Tumor Cell Programmed Cell Death Ligand 1 Expression in Patients with Advanced NSCLC Screened for the ATLANTIC Study

Journal of Thoracic Oncology, 2019
Marietta Scott, Jessica Whiteley, Phillip A Dennis   +2 more
exaly  

Soluble programmed death-ligand 1 are highly expressed in peripheral T-cell lymphoma: a biomarker for prognosis

Hematology, 2019
Haorui Shen, Daobin Zhou, Yan Zhang
exaly  

Exploring the role of programmed cell death protein 1 and its ligand 1 in eye diseases

Critical Reviews in Clinical Laboratory Sciences, 2019
Xiu Wang, Yunshan Cao, Xiaorong Li
exaly  

Prognostic implication of programmed cell death 1 protein and its ligand expressions in endometrial cancer

Gynecologic Oncology, 2018
Jisup Kim, Sinae Kim, Hye Sun Lee
exaly  

A Comprehensive Analysis of Programmed Cell Death Ligand-1 Expression With the Clone SP142 Antibody in Non–Small-Cell Lung Cancer Patients

Clinical Lung Cancer, 2017
Kazuki Takada, Gouji Toyokawa, Tatsuro Okamoto   +2 more
exaly